Researchers of a trial called VITAL, which tracked women and men over 50 for five years, found that vitamin D supplements may help slow biological aging by as much as three years. Another popular ...

About 71% of U.S. adults are either overweight or obese, according to the Centers for Disease Control. That makes it easy to see why there’s currently such ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

While weight-loss drugs like Ozempic work by boosting the hormone GLP-1, research shows certain foods and eating habits can naturally do the same. From fibre-rich meals to olive oil and meal timing, ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

As weight loss medications like Ozempic continue to gain popular, experts and patients are noticing varying effects of the ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...